FEBRUARY 2016 ARTICLE LIST >>
PharmaTutor (February- 2016)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 2)
Received On: 21/09/2015; Accepted On: 28/09/2015; Published On: 01/02/2016
AUTHORS:
Anupriya Kapoor
University Institute Of Pharmacy,
Chhatrapati Shahu Ji Maharaj University, Kanpur, UP, India
anupriya321@gmail.com
ABSTRACT: Non-ionic surfactant vesicles (Niosomes or NSVS) are widely studied as an alternative to hydrated surfactant monomers. Non-ionic surfactants of wide structural types have been found to be useful alternatives to phospholipids in fabrication of vesicular system. They are the microlamellar structures formed by the mixing of Non-ionic surfactant of alkyl or dialkyl polyglycerol ether class and cholesterol with subsequent hydration in aqueous media. This review article deals with the detailed use of Niosome as novel drug delivery system for ophthalmic use, since this route is most frequently used for the treatment of eye infection.
How to cite this article: Kapoor A; An overview on Niosomes- A novel vesicular approach for Ophthalmic Drug Delivery; PharmaTutor; 2016; 4(2); 28-33
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Vyas SP., Khar RK.; Targetted & Controlled Drug Deliery Novel Carrier System; CBS publication; Edn 1st; 2002; pp-249.
2. Uchegbu IF., Vyas SP.; Non-ionic Surfactant based Vesicles (Niosomes) in Drug Delivery; Int. J. Pharmaceutics; 1998; 172(1-2); 33-70.
3. Ludwig A., van Ooteghem M.; Influence of viscolysers on the residence of ophthalmic solutions evaluated by slit lamp fluorophotometry; STP Pharm. Sci. ;1992; 2; 81-87.
4. Aggarwal Deepika, Kaur Indu P; Improved pharmacodynamics of timolol maleated from a mucoadhesive niosomal ophthalmic drug delivery system; Int. J. Pharm.; 2005; 290(1-2); 155 - 159.
5. Yongmei Hao, Fenglin Zhao, Na Li, Yanhong Yang, Ke’an Li.; Studies on a high encapsulation of colchicines by a noisome system; Int. J. Pharm.; 2002; 244(1-2); 73-80.
6. Rogerson A., Cummings J., Willmott N., Florence A.T.; The distribution of doxorubicin in mice following administration in niosomes; J Pharm Pharmacol. 1988; 40(5); 337–342.
7. Baillie A.J., Coombs G.H. , Dolan T.F. ; Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate ; J.Pharm.Pharmacol.; 1986; 38(7); 502-505.
8. Raja Naresh R.A., Chandrashekhar G., Pillai G.K. , Udupa N.; Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats.; Ind. J. Pharmacol.; 1994; 26(1); 46-48.
9. Maver L.D., Bally M.B., Hope. M.J., Cullis P.R.; Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential; Biochimica et Biophysica Acta - Biomembranes; 1985; 816(2); 294-302.
10. Chauhan S. and Luorence M.J.; The preparation of polyoxyethylene containing non-ionic surfactant. Vesicle;. J. Pharm. Pharmacol; 1989; 41.
11. Blazek-Walsh A.I. and Rhodes D.G.; SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes; Pharm. Res; 2001; 18(5); 656-661.
12. Yoshioka T., Stermberg B. and Florence A.T.; Preparation and properties of vesicles (niosomes) of sobitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85); Int J Pharm.; 1994; 105(1); 1-6.
13. Ahmed S. Guinedi, Nahed D. Mortada, Samar Mansour, Rania M. Hathout; Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide; Int. J. Pharm.; 2005; 306(1-2); 71-82.
14. Ame´lie Bochot, Elias Fattal , Jean Louis Grossiord, Francis Puisieux, Patrick Couvreur ; Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel; Int. J. Pharm.; 1998; 162(1-2); 119–127.
15. Aranya manosroi, Paveena wongtrakul, Jiradej manosroi, Hideki sakai, Fumio sugawara, Makoto yuasa, Masahiko abe.; Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol; Colloids and Surfaces B: Biointerfaces; 2003; 30(1); 129-138.
16. Arunothayanun P, Uchegbu IF, Craig DQM, Turton JA, Florence AT.; In vitro/Invivo characterization of polyhedral niosomes; Int. J. Pharm.; 1999; 183(1); 57-61.
17. Ahmed S. Guinedi, Nahed D. Mortada, Samar Mansour, Rania M. Hathout.; Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide; Int. J. Pharm.; 2005; 306(1-2); 71-82.
18. Indu Pal Kaur, Manjit Singh, Meenakshi Kanwar; Formulation and evaluation of ophthalmic preparations of acetazolamide; Int. J. Pharm.; 2000; 199(2); 119-127.
19. Deepika Aggarwal, Dhananjay Pal, Ashim K. Mitra, Indu P. Kaur ; Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor; Int. J. Phar.; 2007; 338(1); 21-26.
20. Faruk Öztürk, Emin Kurt, Ümit Übeyt ?nan, Selim Kortunay, Süleyman sami ?lker, Nursabah E. Ba?c?, Atila Bozkurt; Penetration of topical and oral ofloxacin into the aquous and vitreous humor of inflamed rabbit eyes; Int. J. Pharm.; 2000; 204(1-2); 91-95.
.png)
